CDA | Evidence Driven
CDA | Evidence Driven

Tapentadol

Details

Files
Generic Name:
Tapentadol
Project Status:
Complete
Therapeutic Area:
Pain, moderate to moderately severe
Manufacturer:
Janssen Inc.
Call for patient/clinician input open:
Brand Name:
Nucynta CR
Project Line:
Reimbursement Review
Project Number:
SR0224-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Pain, moderate to moderately severe
Recommendation Type:
Do not list
Final Recommendation:

Files

Submission Status Report View PDF
Recommendation and Reasons View PDF
Plain Language Recommendation View PDF
Last Updated : February 1, 2011